As currently functioning, this core continually evaluates the Partnership's overall performance through the incorporation of quality improvement for the Partnerships inputs, processes, and outcomes. This core develops and defines evaluation targets to be tracked and measured. Also, this core serves by soliciting, evaluating, and funding research projects;facilitating the activities of the Internal Advisory Committee (IAC), the Partnership Advisory Council (PAC), and the Program Steering Committee (PSC);and arranging for planning sessions, retreats, and Summer Institutes. The evaluation plans are implemented by the Partnership Co-Leaders/Coordinators or this core (Dr. Michelle Martin and Dr. Isabel Scarinci). Existence of a 5-year evaluation plan specifically developed for this Partnership framework and details of evaluation strategies are described separately in the Planning and Evaluation Core section of this application.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118623-09
Application #
8734333
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
2014-09-01
Project End
2016-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
9
Fiscal Year
2014
Total Cost
$495,603
Indirect Cost
$177,174
Name
Tuskegee University
Department
Type
DUNS #
128214178
City
Tuskegee
State
AL
Country
United States
Zip Code
36088
Chen, Ina; Mathews-Greiner, Lesley; Li, Dandan et al. (2017) Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med 15:92
Piyathilake, Chandrika J; Badiga, Suguna; Borak, Samuel G et al. (2017) A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 9:413-420
Afolabi, Michael O S; Sodeke, Stephen O (2017) Reconciling Competence and Consent in Opioid-Dependence Research: The Value of Vulnerability Rhetoric. Am J Bioeth 17:48-50
Ahmed, Md Shakir Uddin; Salam, Ahmad Bin; Yates, Clayton et al. (2017) Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer. Int J Nanomedicine 12:6973-6984
Williams, Samuel K; Braxton, Joanne M; Gosdin, Melissa et al. (2017) Evidence-Based Care for the Elderly: Uses of ""the Grandmother Principle"". J Health Care Poor Underserved 28:7
Gao, Song; Wang, Yicun; Wang, Meng et al. (2017) MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 8:41451-41464
Zhang, Guangxin; Zhang, Wei; Li, Bingjin et al. (2017) MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer. Breast Cancer Res 19:73
Afolabi, Michael O S; Sodeke, Stephen O (2017) A Multifaceted Approach Is Needed to Respond to the Plight of Bioethicists in Accessing Literature. Am J Bioeth 17:37-39
Zhang, Yifan; Li, Bingjin; Zhang, Xingyi et al. (2017) CD24 is a genetic modifier for risk and progression of prostate cancer. Mol Carcinog 56:641-650
Sodeke, Stephen O; Wilson, Wylin D (2017) Integrative Bioethics is a Bridge-Builder Worth Considering to Get Desired Results. Am J Bioeth 17:30-32

Showing the most recent 10 out of 129 publications